Skip to main navigation Skip to search Skip to main content

The role of AQP4 in neuromyelitis optica: More answers, more questions

  • Xin Yang
  • , Bruce R. Ransom
  • , Jian-Fang Ma*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord. The presence of antibodies to the water channel protein aquaporin-4 (AQP4), expressed almost exclusively in astrocytes in the central nervous system (CNS), is a reliable biomarker for NMO. These antibodies, NMO-IgG, may be responsible for the sequential cascade of immune events, including IgG/IgM deposition, infiltration of granulocytes and complement-mediated cytotoxicity (i.e. astrocyte loss) and demyelination. This review summarizes current thinking about the role of NMO-IgG in the pathogenesis of this condition. New insights were also generated along with important additional questions.
Original languageEnglish
Pages (from-to)63-70
JournalJournal of Neuroimmunology
Volume298
Online published7 Jun 2016
DOIs
Publication statusPublished - 15 Sept 2016
Externally publishedYes

Research Keywords

  • Complement
  • Demyelination
  • Glutamate
  • Neuromyelitis optica
  • Potassium channel
  • Water channel protein aquaporin-4

Fingerprint

Dive into the research topics of 'The role of AQP4 in neuromyelitis optica: More answers, more questions'. Together they form a unique fingerprint.

Cite this